Scandinavian ChemoTech's subsidiary Vetiqure AB signs agreement with a German AniCura clinic for participation in a study
As previously communicated, Vetiqure AB and three of AniCura's clinics have a collaboration agreement regarding TSE treatment of soft tissue sarcoma in dogs. This agreement is now being updated with a clinic in Germany.
Due to the high workload at AniCura Animal Hospital Albano in Stockholm, which was one of the Swedish clinics that would have participated in the study, a mutual decision has been made between the parties to move the study from this clinic.
As a replacement, Vetiqure, in consultation with AniCura, has identified Dr Ramona Maier, one of the group's most well-known oncologists at the German clinic AniCura Kleintierzentrum Heilbronn. The dialogue between Vetiqure AB and Dr Ramona already started during the Company's successful participation at ESVONC in Italy. The goal is to be able to start patient recruitment in Germany by the end of the fourth quarter. The agreement with the clinic also includes the purchase of TSE treatment kits for the treatments not included in the study.
" It is with great pleasure that I welcome Dr Ramona Maier GPCert in oncology at the AniCura Kleintierzentrum Heilbronn to the study. We met during ESVONC in Italy and Dr Ramona will be a great asset for us in the study and for the continued launch in Europe.” - says Elin Wallin Product Specialist at Vetiqure AB
” Tumour Specific Electroporation (TSE) by Vetiqure is a valuable supplement for the local treatment of tumours. As veterinarians, we find it extremely useful. Above all in cases when surgery is hardly possible (or rather difficult).” – says Dr Ramona Maier, veterinarian – GPCert in oncology at AniCura Kleintierzentrum Heilbronn
The project continues to be run by Leg. veterinarian Nanna Åkerlund Denneberg, Specialist in oncology in dogs and cats, at AniCura Animal Hospital Jönköping. Also participating are Leg. veterinarian Marianne Jensen Mandelin; Specialist in small animal diseases with master's in oncology - dog and cat, at AniCura Jeløy Animal Hospital in Moss.
For further information please contact: Mohan Frick, CEO
+46 (0)10-218 93 00
ir@chemotech.se
Certified Adviser: Erik Penser Bank, Tel: +46 8 463 80 00, E-mail: certifiedadviser@penser.se
Scandinavian ChemoTech AB (publ)
ChemoTech is a Swedish medical technology company based in Lund that has developed a patented technology platform to offer cancer patients access to a new treatment alternative, Tumour Specific Electroporation™ (TSE), available for treatment of both humans and animals. There are a large number of cancer patients whose tumours for various reasons cannot be treated by conventional methods but where TSE can be a solution. Therefore, the company continuously evaluates new opportunities and areas of application for the technology. ChemoTech's shares (CMOTEC B) are listed on Nasdaq First North Growth Market in Stockholm and Erik Penser Bank is the company's Certified Adviser. Read more at: www.chemotech.se.
